Nader, Joëlle <br/><br/>
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.  [electronic resource] 

 -  Neuropharmacology  Dec 2014 
 - 214-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2014.03.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arachidonic Acids--metabolism<br/>Benzamides--pharmacology<br/>Benzodioxoles--pharmacology<br/>Cannabinoid Receptor Modulators--pharmacology<br/>Carbamates--pharmacology<br/>Central Nervous System Stimulants--toxicity<br/>Dronabinol--pharmacology<br/>Endocannabinoids--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Glycerides--metabolism<br/>Male<br/>Methamphetamine--toxicity<br/>Mice, Inbred C57BL<br/>Neostriatum--drug effects<br/>Neurotoxicity Syndromes--metabolism<br/>Piperidines--pharmacology<br/>Polyunsaturated Alkamides--metabolism<br/>Random Allocation<br/>Receptor, Cannabinoid, CB1--agonists<br/>Receptor, Cannabinoid, CB2--agonists<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Tyrosine 3-Monooxygenase--metabolism